<DOC>
	<DOC>NCT01666041</DOC>
	<brief_summary>The investigators hypothesize that fenofibrate/omega will improve insulin resistance compared with fenofibrate</brief_summary>
	<brief_title>Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>hypertriglyceridemia moderate or severe hypertension, uncontrolled diabetes (HbA1c &gt; 9%), nephrotic syndrome, hypothyroidism, coronary artery disease, or peripheral vascular disease</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>insulin resistance</keyword>
</DOC>